| Structure |
Chemical Name |
CAS |
MF |
 |
Donepezil Impurity 3 |
1023500-88-0 |
C24H27NO4 |
 |
Fesoterodine Related Impurity 4 |
214601-12-4 |
C22H29NO2 |
 |
Prasugrel Impurity 14 Maleate |
1373350-60-7 |
C24H25BrFNO7S |
 |
Sofosbuvir Impurity 32 |
1157884-58-6 |
C20H17FO6 |
 |
Torsemide Related Compound 1 |
947327-54-0 |
C13H13N3O2S |
 |
Vortioxetine Impurity 3 |
508233-82-7 |
C17H20N2S |
 |
CYCLOPENTYL BENZOATE |
32651-38-0 |
C12H14O2 |
 |
4,5-ジクロロチオフェン-2-カルボン酸 |
31166-29-7 |
C5H2Cl2O2S |
 |
N,O-Dibenzylated formoterol |
43229-70-5 |
C33H36N2O4 |
 |
Entacapone |
|
|
 |
nifedipine iMpurity |
79781-06-9 |
C17H17N3O7 |
|
|
Linagliptin Impurity A |
|
|
 |
Dehydropitavastatin ethyl ester |
254452-91-0 |
C27H26FNO4 |
 |
(S)-2-(2-oxo-4-propyl-2,5-dihydro-1H-pyrrol-1-yl)butanamide |
357338-13-7 |
C11H18N2O2 |
|
|
Linagliptin Impurity V |
|
|
 |
methyl 2-(4-(2-chloroethyl)phenyl)-2-methylpropanoate |
1181267-33-3 |
C13H17ClO2 |
 |
(2RS)-1-bromo-2-(2,4-difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-2-ol |
150194-52-8 |
C11H10BrF2N3O |
![(S)-2-(((1R,2S,5S)-2-(2-((5-chloropyridin-2-yl)amino)-2-oxoacetamido)-5-(dimethylcarbamoyl)cyclohexyl)carbamoyl)-5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine 5-oxide](/CAS/20180703/GIF/CB93049205.gif) |
(S)-2-(((1R,2S,5S)-2-(2-((5-chloropyridin-2-yl)amino)-2-oxoacetamido)-5-(dimethylcarbamoyl)cyclohexyl)carbamoyl)-5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine 5-oxide |
|
C24H30ClN7O5S |
 |
Clonazepam Related Compound A (3-Amino-4-(2-chlorophenyl)-6-nitrocarbostyril) |
55198-89-5 |
C15H10ClN3O3 |
 |
3-Dehydroxy-3-oxo-4,5-dihydro OxazepaM |
19554-95-1 |
C15H11ClN2O2 |
![3-[3-[[[(7S)-3,4-ジメトキシビシクロ[4.2.0]オクタ-1,3,5-トリエン-7-イル]メチル]メチルアミノ]プロピル]-1,3,4,5-テトラヒドロ-8-ヒドロキシ-7-メトキシ-2H-3-ベンゾアゼピン-2-オン](/CAS/GIF/304464-97-9.gif) |
3-[3-[[[(7S)-3,4-ジメトキシビシクロ[4.2.0]オクタ-1,3,5-トリエン-7-イル]メチル]メチルアミノ]プロピル]-1,3,4,5-テトラヒドロ-8-ヒドロキシ-7-メトキシ-2H-3-ベンゾアゼピン-2-オン |
304464-97-9 |
C26H34N2O5 |
 |
シタロプラムジメチルアミノブタノン DIHYDROCHLORIDE SALT |
1329745-98-3 |
C25H33FN2O2 |
![[[4-[(3-メチルフェニル)アミノ]-3-ピリジニル]スルホニル]カルバミン酸エチルエステル](/CAS/GIF/72810-57-2.gif) |
[[4-[(3-メチルフェニル)アミノ]-3-ピリジニル]スルホニル]カルバミン酸エチルエステル |
72810-57-2 |
C15H17N3O4S |
 |
12-Hydroxy Irinotecan |
185336-12-3 |
C33H38N4O7 |
 |
Losartan IsoMer IMpurity, PotassiuM Salt |
860644-28-6 |
C22H22ClKN6O |
 |
ピドチモドジケトピペラジン-6-プロパン酸 |
161771-75-1 |
C9H12N2O4S |
 |
ロフルミラスト N-オキシド |
292135-78-5 |
C17H14Cl2F2N2O4 |
 |
EsMolol Acid SodiuM Salt |
83356-60-9 |
C15H22NNaO4 |
|
|
Etoricoxib Impurity 18 |
|
|
 |
Ibrutinib Impurity 4 |
1807619-68-6 |
C17H12ClN5O |
|
|
Imatinib Impurity 3 |
|
|
|
|
Mirabegron Impurity 16 |
|
|
|
|
Olaparib Impurity 2 |
|
|
 |
Sofosbuvir Impurity 7 |
1884385-12-9 |
C20H19FO6 |
 |
Vonoprazan Impurity 3 |
928325-41-1 |
C17H15F2N3O2S |
|
|
Cinacalcet Impurity 22 |
|
|
|
|
Dapagliflozin Impurity C |
|
|
|
|
Dasatinib Impurity E |
|
|
|
|
Ixazomib Impurity |
|
|
|
|
Nevirapine Impurity |
|
|
 |
Omarigliptin Impurity |
1819364-01-6 |
C16H18F2N4O |
 |
Palbociclib Impurity 8 |
827022-31-1 |
C31H41N7O4 |
 |
Sitagliptin EP Impurity C |
1345822-86-7 |
C16H19F5N5O5P |
 |
Trifluridine Impurity |
2086328-10-9 |
C10H11F3N2O5 |
|
|
Valsartan related compound H |
|
|
 |
ethyl 2,5-dihydroxybenzenesulfonate |
|
C8H10O5S |
![5-ALLYLIDENE-10,11-DIHYDRO-5H-DIBENZO[A,D]CYCLOHEPTENE](/CAS/GIF/24755-73-5.gif) |
5-ALLYLIDENE-10,11-DIHYDRO-5H-DIBENZO[A,D]CYCLOHEPTENE |
24755-73-5 |
C18H16 |
|
|
Nintedanib Impurity 27 |
|
|
 |
ethyl 2-(2-formyl-3-hydroxyphenyl)-4-methylthiazole-5- carboxylate |
|
C14H13NO4S |
 |
LUMAT-004 |
313544-31-9 |
C16H17N3O3 |
 |
Varenicline Impurity 3 |
1333145-89-3 |
C14H15N3 |
 |
Amlodipine Impurity 22 (Z-Isomer) |
|
C26H31ClN2O8S |
 |
Amlodipine Impurity 28 |
79781-21-8 |
C18H20ClNO5 |
![Imidazo[5,1-f][1,2,4]triazin-4(1H)-one, 2-[2-ethoxy-5-[(4-ethyl-4-oxido-1-piperazinyl)sulfonyl]phenyl]-5-methyl-7-propyl-](/CAS/20210111/GIF/448184-48-3.gif) |
Imidazo[5,1-f][1,2,4]triazin-4(1H)-one, 2-[2-ethoxy-5-[(4-ethyl-4-oxido-1-piperazinyl)sulfonyl]phenyl]-5-methyl-7-propyl- |
448184-48-3 |
C23H32N6O5S |
 |
(R)-N,N-dimethyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine |
878757-08-5 |
C19H21NOS |
|
|
Capecitabine Impurity 10 |
|
|
|
|
Carfilzomib Impurity C |
|
|
 |
Cefathiamidine Impurity 4 |
1418224-75-5 |
C10H11BrN2O5S |
|
|
Cefodizime Impurity 2 |
|
|
 |
Choline Fenofibrate Impurity 1 |
2985-79-7 |
C13H9ClO2 |
|
|
DecitaBine Impurity 11 |
|
|
 |
Isavuconazole Impurity 21 |
3094994-76-7 |
C13H14F2N4OS |
 |
Thyroxine Ethyl Ester |
76353-71-4 |
C17H15I4NO4 |
![(4-クロロフェニル)[4-(1-メチルエトキシ)フェニル]メタノン(FENOFIBRATE IMPURITY)](/CAS/GIF/154356-96-4.gif) |
(4-クロロフェニル)[4-(1-メチルエトキシ)フェニル]メタノン(FENOFIBRATE IMPURITY) |
154356-96-4 |
C16H15ClO2 |
 |
5-Acetyl Rhein |
875535-35-6 |
C17H10O7 |
 |
7'-メチル-2'-プロピル-2,5'-BI-1H-ベンズイミダゾール |
884330-09-0 |
C18H18N4 |
![5-Des[2-(tert-butylaMino)] BaMbuterol-5-ethanol](/CAS/GIF/112935-93-0.gif) |
5-Des[2-(tert-butylaMino)] BaMbuterol-5-ethanol |
112935-93-0 |
C14H20N2O5 |
 |
Deoxy Fesoterodine |
895137-81-2 |
C26H37NO2 |
![Bisacodyl Related Compound C (20 mg) (4-[(4-Hydroxyphenyl)(pyridin-2-yl)methyl]phenyl acetate)](/CAS/GIF/72901-16-7.gif) |
Bisacodyl Related Compound C (20 mg) (4-[(4-Hydroxyphenyl)(pyridin-2-yl)methyl]phenyl acetate) |
72901-16-7 |
C20H17NO3 |
![(6R,7R)-7-((Z)-2-(2-aMinothiazol-4-yl)-2-(hydroxyiMino)acetaMido)-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 5-oxide](/CAS/GIF/934986-48-8.gif) |
(6R,7R)-7-((Z)-2-(2-aMinothiazol-4-yl)-2-(hydroxyiMino)acetaMido)-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 5-oxide |
934986-48-8 |
C14H13N5O6S2 |
![(2S)-1-[(2S)-2-Methyl-3-Methylsulfinylpropanoyl]pyrrolidine-2-carboxylic acid](/CAS/20130318/GIF/CB32605020.gif) |
(2S)-1-[(2S)-2-Methyl-3-Methylsulfinylpropanoyl]pyrrolidine-2-carboxylic acid |
78636-31-4 |
C14H22N2O6S2 |
|
|
Mixture of diastereoisoMers of (6S)-6-N-[3-[(6S)-2-aMino-4,5, 6,7-tetrahydro-1,3-benzothiazol-6-yl]-1-ethyl-2-Methylpropyl]- 4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diaMine |
|
|
|
|
penilloic acids of piperacillin |
|
|
 |
2-PyrazinecarboxaMide, 6-nitro-3,4-dihydro-3-oxo- |
259793-97-0 |
C5H4N4O4 |
 |
Dolutegravir 4-Desfluoro Impurity |
1863916-87-3 |
C20H20FN3O5 |
 |
Tetrabenazine Dehydro Impurity |
100322-43-8 |
C19H25NO3 |
 |
Cefotiam Impurity 22 |
1628441-07-5 |
C13H14N4O5S2 |
 |
Dezocine Impurity 2 |
100667-17-2 |
C16H21NO |
 |
loteprednol Impurity 7 |
82034-20-6 |
C24H33ClO7 |
 |
Sitagliptin Impurity 28 |
898543-70-9 |
C32H25F12N9O2 |
 |
Vilanterol Impurity 3 Triphenylacetate |
503070-62-0 |
C23H31Cl2NO5 |
|
|
Empagliflozin Impurity 33 |
|
|
 |
Sugammadex Impurity 21 |
2412952-93-1 |
C72H113NaO48S8 |
 |
4-((1,4,8,11-tetraazacyclotetradecan-1-yl)methyl)benzaldehyde trihydrochloride |
1254176-45-8 |
C18H30N4O |
 |
ネブラミン |
34051-04-2 |
C12H26N4O5 |
 |
Remifentanil Impurity 1 (RTF-02) |
938184-94-2 |
C16H21N3O2 |
![methyl (3aS,4R,6S,6aR)-4-((tert-butoxycarbonyl)amino)-3-(pentan-3-yl)-3a,5,6,6a-tetrahydro-4H-cyclopenta[d]isoxazole-6-carboxylate](/CAS/20200611/GIF/383910-25-6.gif) |
methyl (3aS,4R,6S,6aR)-4-((tert-butoxycarbonyl)amino)-3-(pentan-3-yl)-3a,5,6,6a-tetrahydro-4H-cyclopenta[d]isoxazole-6-carboxylate |
383910-25-6 |
C18H30N2O5 |
 |
sodium (((((R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy) methyl)oxidophosphoryl)-L-alaninate |
382140-24-1 |
C12H19N6O5P |
|
|
Zopiclone Impurity 13 |
|
|
 |
1-メチルインドリン-2,3-ジオン |
2058-74-4 |
C9H7NO2 |
 |
1-bromo-3-(4-ethoxybenzyl)benzene |
898538-17-5 |
C15H15BrO |
 |
(2S,3R,4R,5S,6R)-2-(4-chloro-3-((4-ethoxyphenyl)(methoxy) methyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol |
1318794-28-3 |
C22H27ClO7 |
 |
Brivaracetam Impurity |
2432911-37-8 |
C11H22O3 |
|
|
Cefminox Sodium impurity 5 |
|
|
 |
Moxifloxacin Impurity 37 |
1803729-19-2 |
C7H3ClF2O2 |
 |
Nimodipine Impurity 12 |
39562-18-0 |
C19H22N2O6 |
|
|
Rosuvastatin Impurity 53 |
|
|
 |
Sulbactam Impurity 8 |
75527-88-7 |
C8H10BrNO5S |
 |
Tenofovir Impurity 64 |
1878175-76-8 |
C13H23N5O8P2 |
|
|
Ticagrelor Impurity 65 |
|
|